• News

pharminent June 22, 2026

• News

AbbVie to Acquire Apogee Therapeutics for Nearly $11 Billion in Immunology Bet

pharminent June 22, 2026

• M&A / Deals

AbbVie climbs post-Allergan M&A peak with Apogee buy

pharminent June 22, 2026

• M&A / Deals

Lilly bets up to $800M for BioArctic’s brain delivery tech

pharminent June 22, 2026

• Clinical Data

Boehringer advances duo for aggressive cancers into phase 3

pharminent June 22, 2026

• M&A / Deals

Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance

pharminent June 22, 2026

• Commercial

Post-marketing oncology studies: Enabling faster recruitment and lower costs

pharminent June 22, 2026

• M&A / Deals

Sun Pharma to acquire Innovcare Lifesciences for $28.7m

pharminent June 22, 2026

• Commercial

The first 14 days: How specialty programs set patients up for success

pharminent June 22, 2026

• Regulatory

Japan approves Sanofi’s Sarclisa combo for MM treatment

pharminent June 22, 2026

• News

pharminent June 19, 2026

• News

pharminent June 19, 2026

• Commercial

Denali sells FDA voucher for $195M to support neurodegenerative pipeline

pharminent June 19, 2026

• Policy / Pricing

US launches probe of German ‘underpayment’ for medicines

pharminent June 19, 2026

• M&A / Deals

Biogen to acquire RayThera for up to $1bn

pharminent June 19, 2026

• Regulatory

FDA experts endorse Moderna’s mRNA seasonal flu shot

pharminent June 19, 2026

• Policy / Pricing

FDA’s new voucher program hints at broader policy agenda, making many ‘uncomfortable’

pharminent June 19, 2026

• News

pharminent June 18, 2026

• Regulatory

Moderna flu vaccine wins unanimous support from FDA panel

pharminent June 18, 2026

• News

pharminent June 18, 2026

• Regulatory

MSD takes on Pfizer’s Prevnar with new Capvaxive approval

pharminent June 18, 2026

• Pipeline

New biotech cAMPfield emerges with $180M to reshape IBD treatment

pharminent June 18, 2026

• M&A / Deals

Heart drug biotech Kardigan raises $400m in upscaled IPO

pharminent June 18, 2026

• M&A / Deals

Cardio biotech Kardigan binds off $400M upsized IPO

pharminent June 18, 2026

• Regulatory

GSK claims FDA okay for first oral carbapenem antibiotic

pharminent June 18, 2026

• M&A / Deals

LG AI Research and D&D Pharmatech sign agreement for oral peptide drugs

pharminent June 18, 2026

• M&A / Deals

Biogen pens $1bn deal to buy immunology biotech RayThera

pharminent June 18, 2026

• Manufacturing

pharminent June 17, 2026

• News

pharminent June 17, 2026

• Gene Therapy

UniQure to file gene therapy for approval, reflecting major shifts at FDA

pharminent June 17, 2026

• Regulatory

uniQure sets course to US filing for Huntington gene therapy

pharminent June 17, 2026

• M&A / Deals

Jazz orchestrates a $4bn cancer alliance with AbCellera

pharminent June 17, 2026

• Clinical Data

Edgewise slides as cardiomyopathy challenger to BMS, Cytokinetics falls short

pharminent June 17, 2026

• M&A / Deals

Merck adds to biopharma’s AI agenda with up to $510M+ Protillion pact

pharminent June 17, 2026

• Commercial

Moderna builds commercial muscle as new launches loom

pharminent June 17, 2026

• M&A / Deals

Altaris to acquire Simulations Plus in $375m all-cash deal

pharminent June 17, 2026

• Clinical Data

EHA26: BMS touts positive multiple myeloma data for two pipeline candidates

pharminent June 17, 2026

• News

pharminent June 16, 2026

• News

pharminent June 16, 2026

• Regulatory

FDA, Moderna appear aligned on mRNA flu shot heading into adcomm

pharminent June 16, 2026